{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:03:01Z","timestamp":1783976581345,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T00:00:00Z","timestamp":1482364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T00:00:00Z","timestamp":1482364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thyroid dysfunction is associated with poor prognosis in heart failure, but theories of mechanisms are mainly based on animal experiments, not on human level. We aimed to explore the relation between thyroid function and myocardial injuries in idiopathic dilated cardiomyopathy (IDCM) using cardiac magnetic resonance imaging (MRI), single-photon emission computed tomography (SPECT) and positron emission tomography (PET). Myocardial fibrosis was detected by late gadolinium enhancement (LGE) MRI, and myocardial perfusion\/metabolism was evaluated by <jats:sup>99m<\/jats:sup>Tc-MIBI SPECT \/<jats:sup>18<\/jats:sup>F-FDG PET imaging. Across the quartiles of FT3, decreased percentage of segments with LGE and perfusion\/metabolism abnormalities were found. As for FT4 and TSH levels, no significant distribution trend of myocardial injuries could be detected. In logistic analysis, FT3 was independently associated with the presence of LGE (OR: 0.140, 95% CI: 0.035\u20130.567), perfusion abnormalities (OR: 0.172, 95% CI: 0.040\u20130.738) and metabolism abnormalities (OR: 0.281, 95% CI: 0.081\u20130.971). After a median follow-up of 46 months, LGE-positive and FT3\u2009&lt;\u20092.77\u2009pg\/mL was identified as the strongest predictor of cardiac events (HR: 8.623, 95% CI: 3.626\u201316.438). Low FT3 level is associated with myocardial fibrosis and perfusion\/metabolism abnormalities in patients with IDCM. The combination of FT3 level and LGE provides useful information for assessing the prognosis of IDCM.<\/jats:p>","DOI":"10.1038\/srep39811","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T12:47:45Z","timestamp":1482410865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Free Triiodothyronine Level Correlates with Myocardial Injury and Prognosis in Idiopathic Dilated Cardiomyopathy: Evidence from Cardiac MRI and SPECT\/PET Imaging"],"prefix":"10.1038","volume":"6","author":[{"given":"Wenyao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Martin","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Iervasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Da","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,22]]},"reference":[{"key":"BFsrep39811_CR1","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1210\/jc.2013-4184","volume":"99","author":"C Selmer","year":"2014","unstructured":"Selmer, C. et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J. Clin. Endocrinol. Metab. 99, 2372\u20132382 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFsrep39811_CR2","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1210\/jc.2011-1978","volume":"97","author":"D Nanchen","year":"2012","unstructured":"Nanchen, D. et al. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J. Clin. Endocrinol. Metab. 97, 852\u2013861 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFsrep39811_CR3","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.096024","volume":"126","author":"B Gencer","year":"2012","unstructured":"Gencer, B. et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation 126, 1040\u20131049 (2012).","journal-title":"Circulation"},{"key":"BFsrep39811_CR4","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1210\/jc.2014-4159","volume":"100","author":"W Wang","year":"2015","unstructured":"Wang, W. et al. Thyroid Status, Cardiac Function, and Mortality in Patients With Idiopathic Dilated Cardiomyopathy. J. Clin. Endocrinol. Metab. 100, 3210\u20133218 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFsrep39811_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ejhf.54","volume":"16","author":"A Roos","year":"2014","unstructured":"Roos, A., Links, T. P. & Wolffenbuttel, B. H. Subclinical thyroid disease and heart failure. Eur. J. Heart Fail. 16, 119\u2013121 (2014).","journal-title":"Eur. J. Heart Fail."},{"key":"BFsrep39811_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/ejhf.42","volume":"16","author":"S Chen","year":"2014","unstructured":"Chen, S. et al. The effect of thyroid function on clinical outcome in patients with heart failure. Eur. J. Heart Fail. 16, 217\u2013226 (2014).","journal-title":"Eur. J. Heart Fail."},{"key":"BFsrep39811_CR7","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1161\/CIRCULATIONAHA.105.572883","volume":"112","author":"YD Tang","year":"2005","unstructured":"Tang, Y. D. et al. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation 112, 3122\u20133130 (2005).","journal-title":"Circulation"},{"key":"BFsrep39811_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mce.2014.04.010","volume":"391","author":"AL de Castro","year":"2014","unstructured":"de Castro, A. L. et al. Cardioprotective effects of thyroid hormones in a rat model of myocardial infarction are associated with oxidative stress reduction. Mol. Cell. Endocrinol. 391, 22\u201329 (2014).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFsrep39811_CR9","doi-asserted-by":"publisher","first-page":"R340","DOI":"10.1152\/ajpregu.00449.2013","volume":"307","author":"J Suarez","year":"2014","unstructured":"Suarez, J. et al. In vivo selective expression of thyroid hormone receptor alpha1 in endothelial cells attenuates myocardial injury in experimental myocardial infarction in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R340\u2013346 (2014).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFsrep39811_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/cvr\/cvp304","volume":"85","author":"MA Carrillo-Sepulveda","year":"2010","unstructured":"Carrillo-Sepulveda, M. A. et al. Thyroid hormone stimulates NO production via activation of the PI3K\/Akt pathway in vascular myocytes. Cardiovasc. Res. 85, 560\u2013570 (2010).","journal-title":"Cardiovasc. Res."},{"key":"BFsrep39811_CR11","doi-asserted-by":"publisher","first-page":"e61982","DOI":"10.1371\/journal.pone.0061982","volume":"8","author":"MA Carrillo-Sepulveda","year":"2013","unstructured":"Carrillo-Sepulveda, M. A. et al. Emerging role of angiotensin type 2 receptor (AT2R)\/Akt\/NO pathway in vascular smooth muscle cell in the hyperthyroidism. PLoS One 8, e61982 (2013).","journal-title":"PLoS One"},{"key":"BFsrep39811_CR12","doi-asserted-by":"publisher","first-page":"14104","DOI":"10.1073\/pnas.0601600103","volume":"103","author":"Y Hiroi","year":"2006","unstructured":"Hiroi, Y. et al. Rapid nongenomic actions of thyroid hormone. Proc. Natl. Acad. Sci. USA 103, 14104\u201314109 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep39811_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.matbio.2006.12.005","volume":"26","author":"S Ghose Roy","year":"2007","unstructured":"Ghose Roy, S., Mishra, S., Ghosh, G. & Bandyopadhyay, A. Thyroid hormone induces myocardial matrix degradation by activating matrix metalloproteinase-1. Matrix Biol. 26, 269\u2013279 (2007).","journal-title":"Matrix Biol."},{"key":"BFsrep39811_CR14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1161\/01.RES.71.4.831","volume":"71","author":"J Yao","year":"1992","unstructured":"Yao, J. & Eghbali, M. Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy. Response of cardiac fibroblasts to thyroid hormone in vitro. Circ. Res. 71, 831\u2013839 (1992).","journal-title":"Circ. Res."},{"key":"BFsrep39811_CR15","doi-asserted-by":"crossref","unstructured":"Nicolini, G. et al. Early and short-term triiodothyronine supplementation prevents adverse post-ischemic cardiac remodeling: role of transforming growth factor-beta1 and anti-fibrotic miRNA signaling. Mol. Med. (2015).","DOI":"10.2119\/molmed.2015.00140"},{"key":"BFsrep39811_CR16","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jama.2013.1363","volume":"309","author":"A Gulati","year":"2013","unstructured":"Gulati, A. et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309, 896\u2013908 (2013).","journal-title":"JAMA"},{"key":"BFsrep39811_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","volume":"7","author":"S Kuruvilla","year":"2014","unstructured":"Kuruvilla, S. et al. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ. Cardiovasc. Imaging 7, 250\u2013258 (2014).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"BFsrep39811_CR18","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/RLU.0b013e3182708794","volume":"37","author":"L Wang","year":"2012","unstructured":"Wang, L., Yan, C., Zhao, S. & Fang, W. Comparison of (99\u2009m)Tc-MIBI SPECT\/18F-FDG PET imaging and cardiac magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy: assessment of cardiac function and myocardial injury. Clin. Nucl. Med. 37, 1163\u20131169 (2012).","journal-title":"Clin. Nucl. Med."},{"key":"BFsrep39811_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","volume":"93","author":"P Richardson","year":"1996","unstructured":"Richardson, P. et al. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93, 841\u2013842 (1996).","journal-title":"Circulation"},{"key":"BFsrep39811_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1432-2277.2001.tb00063.x","volume":"14","author":"N de Leeuw","year":"2001","unstructured":"de Leeuw, N. et al. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl. Int. 14, 299\u2013306 (2001).","journal-title":"Transpl. Int."},{"key":"BFsrep39811_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0303-7207(00)00203-3","volume":"162","author":"WJ Chen","year":"2000","unstructured":"Chen, W. J., Lin, K. H. & Lee, Y. S. Molecular characterization of myocardial fibrosis during hypothyroidism: evidence for negative regulation of the pro-alpha1(I) collagen gene expression by thyroid hormone receptor. Mol. Cell. Endocrinol. 162, 45\u201355 (2000).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFsrep39811_CR22","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1111\/j.1582-4934.2012.01593.x","volume":"16","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. Thyroid hormone induces sprouting angiogenesis in adult heart of hypothyroid mice through the PDGF-Akt pathway. J. Cell. Mol. Med. 16, 2726\u20132735 (2012).","journal-title":"J. Cell. Mol. Med."},{"key":"BFsrep39811_CR23","doi-asserted-by":"publisher","first-page":"H2409","DOI":"10.1152\/ajpheart.00483.2005","volume":"289","author":"WI Khalife","year":"2005","unstructured":"Khalife, W. I. et al. Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 289, H2409\u20132415 (2005).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFsrep39811_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0735-1097(99)00499-4","volume":"35","author":"AF van den Heuvel","year":"2000","unstructured":"van den Heuvel, A. F. et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 35, 19\u201328 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFsrep39811_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF02990476","volume":"14","author":"H Yamaguchi","year":"2000","unstructured":"Yamaguchi, H. et al. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy. Ann. Nucl. Med. 14, 33\u201338 (2000).","journal-title":"Ann. Nucl. Med."},{"key":"BFsrep39811_CR26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/clc.20132","volume":"30","author":"S Baycan","year":"2007","unstructured":"Baycan, S. et al. Coronary flow reserve is impaired in subclinical hypothyroidism. Clin. Cardiol. 30, 562\u2013566 (2007).","journal-title":"Clin. Cardiol."},{"key":"BFsrep39811_CR27","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1210\/jcem.85.5.6520","volume":"85","author":"FM Bengel","year":"2000","unstructured":"Bengel, F. M. et al. Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. J. Clin. Endocrinol. Metab. 85, 1822\u20131827 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFsrep39811_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1210\/en.2010-0431","volume":"152","author":"CJ Pol","year":"2011","unstructured":"Pol, C. J. et al. Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. Endocrinology 152, 669\u2013679 (2011).","journal-title":"Endocrinology"},{"key":"BFsrep39811_CR29","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1161\/CIRCULATIONAHA.108.834424","volume":"119","author":"S Goldman","year":"2009","unstructured":"Goldman, S. et al. DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study. Circulation 119, 3093\u20133100 (2009).","journal-title":"Circulation"},{"key":"BFsrep39811_CR30","doi-asserted-by":"publisher","first-page":"e7895","DOI":"10.1136\/bmj.e7895","volume":"345","author":"C Selmer","year":"2012","unstructured":"Selmer, C. et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ 345, e7895 (2012).","journal-title":"BMJ"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep39811.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39811","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39811.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T01:15:17Z","timestamp":1672881317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep39811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep39811"],"URL":"https:\/\/doi.org\/10.1038\/srep39811","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,22]]},"assertion":[{"value":"19 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39811"}}